# Deciphering the Genetic Complexity of Classical Hodgkin Lymphoma: Insights and Effective Strategies

**Authors:** Chaeyoung Lee, Yeeun An

PMC · DOI: 10.2174/0113892029301904240513045755 · Current Genomics · 2024-05-24

## TL;DR

This paper explores the genetic factors behind classical Hodgkin lymphoma, focusing on the rare tumor cells and their interactions with the surrounding environment.

## Contribution

The paper proposes new strategies to better understand cHL's genetic complexity using advanced technologies and targeted analyses.

## Key findings

- HRS cells show hyperactive signaling in pathways like NF-kB, aiding their survival and proliferation.
- Susceptibility genes from genome-wide studies have unclear roles in general cancer susceptibility.
- Strategies like single-cell analysis and subtype-specific investigations are recommended for future research.

## Abstract

Understanding the genetics of susceptibility to classical Hodgkin lymphoma (cHL) is considerably limited compared to other cancers due to the rare Hodgkin and Reed-Sternberg (HRS) tumor cells, which coexist with the predominant non-malignant microenvironment. This article offers insights into genetic abnormalities in cHL, as well as nucleotide variants and their associated target genes, elucidated through recent technological advancements. Oncogenomes in HRS cells highlight the survival and proliferation of these cells through hyperactive signaling in specific pathways (e.g., NF-kB) and their interplay with microenvironmental cells (e.g., CD4+ T cells). In contrast, the susceptibility genes identified from genome-wide association studies and expression quantitative trait locus analyses only vaguely implicate their potential roles in susceptibility to more general cancers. To pave the way for the era of precision oncology, more intensive efforts are imperative, employing the following strategies: exploring genetic heterogeneity by gender and cHL subtype, investigating colocalization with various types of expression quantitative trait loci, and leveraging single-cell analysis. These approaches provide valuable perspectives for unraveling the genetic complexities of cHL.

## Linked entities

- **Proteins:** NFKB1 (nuclear factor kappa B subunit 1)
- **Diseases:** classical Hodgkin lymphoma (MONDO:0009348), cHL (MONDO:0009348)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** Hodgkin and Reed-Sternberg (HRS) tumor (MESH:C535516), Classical Hodgkin Lymphoma (MESH:D006689), genetic abnormalities (MESH:D030342), cancers (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11420564/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11420564/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC11420564/full.md

---
Source: https://tomesphere.com/paper/PMC11420564